ArticleCureus2025
A Unique Case Series of Endometrial Vascular Dystrophy: Rising Incidence and Association With Uterine Pathologies.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Endometrial vascular dystrophy (EVD) is a rare hysteroscopic finding characterized by abnormal, tortuous, and dilated endometrial vessels, most often associated with abnormal uterine bleeding (AUB). Despite its potential clinical impact, global literature on EVD remains scant. This case series describes three women diagnosed with EVD. Case 1 involved a 41-year-old multiparous woman presenting with heavy menstrual bleeding in the current cycle, which was earlier than usual; hysteroscopy revealed diffuse bluish, tortuous vessels coexisting with an isthmocele. Case 2 was a 50-year-old nulliparous woman with prolonged AUB and a history of MRI-guided high-intensity focused ultrasound ablation (MR-HIFU); hysteroscopy demonstrated diffuse EVD. Case 3 reported a 45-year-old woman on intermittent exogenous progesterone for a year, whose EVD distribution was sparse and observed alongside intrauterine adhesions. In each case, histopathology confirmed secretory endometrium with or without dilated glands. All the patients had symptom management. Notably, EVD changes coexisted with diverse endometrial pathological entities but were absent in isthmocele regions. A novel possible association of EVD with post-HIFU uterine changes was observed. This series illustrates the diagnostic value of hysteroscopy in identifying EVD as an under-recognized cause of AUB and highlights its possible coexistence with other endometrial pathologies. EVD appears benign and often self-limiting; however, its expanded recognition is essential, and further research is warranted to elucidate its long-term clinical significance, associations, and targeted management strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.